Key points are not available for this paper at this time.
The first in-human demonstration of aptamer sensors is reported; these have the potential to enable continuous molecular monitoring beyond glucose.
Friedel et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: